Form 8-K - Current report:
SEC Accession No. 0001193125-24-257374
Filing Date
2024-11-13
Accepted
2024-11-13 17:21:02
Documents
15
Period of Report
2024-11-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d873918d8k.htm   iXBRL 8-K 29988
2 EX-99.1 d873918dex991.htm EX-99.1 4892
  Complete submission text file 0001193125-24-257374.txt   220139

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA abp-20241113.xsd EX-101.SCH 3128
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abp-20241113_def.xml EX-101.DEF 16394
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE abp-20241113_lab.xml EX-101.LAB 27010
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abp-20241113_pre.xml EX-101.PRE 17132
17 EXTRACTED XBRL INSTANCE DOCUMENT d873918d8k_htm.xml XML 7674
Mailing Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013
Business Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013 248-890-7200
Abpro Holdings, Inc. (Filer) CIK: 0001893219 (see all company filings)

EIN.: 871013956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41224 | Film No.: 241455743
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)